Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele

To develop a peptide vaccine for cancer patients with the HLA-A26 allele, which is a minor population worldwide, we investigated the immunological responses of HLA-A26(+)/A26(+) cancer patients to four different CTL epitope peptides under personalized peptide vaccine regimens. In personalized peptid...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Shinjiro, Matsueda, Satoko, Takamori, Shinzo, Toh, Uhi, Noguchi, Masanori, Yutani, Shigeru, Yamada, Akira, Shichijo, Shigeki, Yamada, Teppei, Suekane, Shigetaka, Kawano, Kouichiro, Sasada, Tetsuro, Hattori, Noboru, Kohno, Nobuoki, Itoh, Kyogo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638024/
https://www.ncbi.nlm.nih.gov/pubmed/26212219
http://dx.doi.org/10.1111/cas.12757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638024/
https://www.ncbi.nlm.nih.gov/pubmed/26212219
http://dx.doi.org/10.1111/cas.12757

Ejemplares similares